NovImmune SA Appoints Andrew J. Oakley As CFO

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Swiss biotech company Novimmune (IPO-NOVI.S), seen as a potential IPO candidate, said on Wednesday it has appointed former Actelion CFO Andrew J. Oakley as its new finance chief.

Oakley, a UK and Australian citizen who was CFO of Actelion for a decade, stepped down from the company last August to focus on other opportunities.

Help employers find you! Check out all the jobs and post your resume.

Back to news